LMCYX | VEVYX | LMCYX / VEVYX | |
Total Expense Ratio | 0.78 | 0.66 | 118% |
Annual Report Gross Expense Ratio | 0.78 | 0.66 | 118% |
Fund Existence | 26 years | 13 years | - |
Gain YTD | -2.312 | 1.133 | -204% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.1B | 17.2B | 6% |
Annual Yield % from dividends | 0.81 | 1.08 | 75% |
Returns for 1 year | -6.99 | -7.20 | 97% |
Returns for 3 years | 7.30 | -2.80 | -261% |
Returns for 5 years | 35.36 | 34.80 | 102% |
Returns for 10 years | 30.37 | 45.03 | 67% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 27.57 | 0.21 | +0.79% |
First Trust Nasdaq Pharmaceuticals ETF | |||
HACK | 82.90 | 0.47 | +0.57% |
Amplify Cybersecurity ETF | |||
IGBH | 24.48 | 0.06 | +0.25% |
iShares Interest Rate Hdg L/T Corp BdETF | |||
SCDS | 56.45 | N/A | N/A |
JPMorgan Fundamental Data Sci Sm Cor ETF | |||
HIO | 3.94 | -0.02 | -0.51% |
Western Asset High Income Opportunity Fund |